A subscription to IJPC includes a print copy delivered by postal mail and on-line access to electronic PDF copies of your subscribed issues.
Erlotinib 10-mg/mL Oral Suspension
Author(s): Allen Loyd V Jr
Issue: Nov/Dec 2016 - Volume 20, Number 6
View All Articles in Issue
Abstract: A formulation for preparing Erlotinib 10-mg/mL Oral Suspension. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.
Related Keywords: Loyd V. Allen, Jr., PhD, RPh, formulation, erlotinib, hazardous medication, cancer, antineoplastic agent, EGFR inhibitor
Related Categories: CANCER AND AIDS, FORMULATIONS, HAZARDOUS DRUGS
Download in electronic PDF format for $45
